These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 17586424

  • 1. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T, Schmidt EB, Christensen JH.
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [Abstract] [Full Text] [Related]

  • 2. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study.
    Madsen T, Christensen JH, Blom M, Schmidt EB.
    Br J Nutr; 2003 Apr; 89(4):517-22. PubMed ID: 12654170
    [Abstract] [Full Text] [Related]

  • 3. Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study.
    Christensen JH, Aarøe J, Knudsen N, Dideriksen K, Kornerup HJ, Dyerberg J, Schmidt EB.
    Clin Nephrol; 1998 Feb; 49(2):102-6. PubMed ID: 9524780
    [Abstract] [Full Text] [Related]

  • 4. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [Abstract] [Full Text] [Related]

  • 5. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men.
    Poudel-Tandukar K, Nanri A, Matsushita Y, Sasaki S, Ohta M, Sato M, Mizoue T.
    Nutr Res; 2009 Jun; 29(6):363-70. PubMed ID: 19628101
    [Abstract] [Full Text] [Related]

  • 6. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients.
    Ewers B, Riserus U, Marckmann P.
    J Ren Nutr; 2009 Sep; 19(5):401-11. PubMed ID: 19541503
    [Abstract] [Full Text] [Related]

  • 7. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study.
    Madsen T, Christensen JH, Schmidt EB.
    Eur J Nutr; 2007 Oct; 46(7):428-30. PubMed ID: 17676423
    [Abstract] [Full Text] [Related]

  • 8. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients.
    Begum R, Belury MA, Burgess JR, Peck LW.
    J Ren Nutr; 2004 Oct; 14(4):233-41. PubMed ID: 15483784
    [Abstract] [Full Text] [Related]

  • 9. Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure.
    Eschen O, Christensen JH, LA Rovere MT, Romano P, Sala P, Schmidt EB.
    Cell Mol Biol (Noisy-le-grand); 2010 Feb 25; 56(1):45-51. PubMed ID: 20196969
    [Abstract] [Full Text] [Related]

  • 10. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects.
    Geelen A, Brouwer IA, Schouten EG, Kluft C, Katan MB, Zock PL.
    Eur J Clin Nutr; 2004 Oct 25; 58(10):1440-2. PubMed ID: 15100717
    [Abstract] [Full Text] [Related]

  • 11. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
    Dyerberg J, Eskesen DC, Andersen PW, Astrup A, Buemann B, Christensen JH, Clausen P, Rasmussen BF, Schmidt EB, Tholstrup T, Toft E, Toubro S, Stender S.
    Eur J Clin Nutr; 2004 Jul 25; 58(7):1062-70. PubMed ID: 15220949
    [Abstract] [Full Text] [Related]

  • 12. Effect of a sardine supplement on C-reactive protein in patients receiving hemodialysis.
    Moreira AC, Gaspar A, Serra MA, Simões J, Lopes da Cruz J, Amaral TF.
    J Ren Nutr; 2007 May 25; 17(3):205-13. PubMed ID: 17462553
    [Abstract] [Full Text] [Related]

  • 13. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
    Rasmussen LE, Svensson M, Jørgensen KA, Schmidt EB, Christensen JH.
    Nutr Res; 2010 Aug 25; 30(8):535-40. PubMed ID: 20851307
    [Abstract] [Full Text] [Related]

  • 14. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    J Ren Nutr; 2007 Jul 25; 17(4):243-9. PubMed ID: 17586422
    [Abstract] [Full Text] [Related]

  • 15. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
    Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Sobajic S, Djuric I, Ristic D.
    Ren Fail; 2007 Jul 25; 29(3):321-9. PubMed ID: 17497447
    [Abstract] [Full Text] [Related]

  • 16. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN.
    Nephrol Dial Transplant; 2007 Dec 25; 22(12):3561-7. PubMed ID: 17623719
    [Abstract] [Full Text] [Related]

  • 17. No effect of fish oil supplementation on serum inflammatory markers and their interrelationships: a randomized controlled trial in healthy, middle-aged individuals.
    Pot GK, Brouwer IA, Enneman A, Rijkers GT, Kampman E, Geelen A.
    Eur J Clin Nutr; 2009 Nov 25; 63(11):1353-9. PubMed ID: 19623203
    [Abstract] [Full Text] [Related]

  • 18. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.
    Bowden RG, Wilson RL, Deike E, Gentile M.
    Nutr Clin Pract; 2009 Nov 25; 24(4):508-12. PubMed ID: 19461006
    [Abstract] [Full Text] [Related]

  • 19. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
    Bowden RG, Jitomir J, Wilson RL, Gentile M.
    J Ren Nutr; 2009 Jul 25; 19(4):259-66. PubMed ID: 19539180
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
    Hanefeld M, Marx N, Pfützner A, Baurecht W, Lübben G, Karagiannis E, Stier U, Forst T.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):290-7. PubMed ID: 17239709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.